Moneycontrol
HomeNewsIndiaSterling Biotech bank fraud: The reputation and independence of CBI at stake
Trending Topics

Sterling Biotech bank fraud: The reputation and independence of CBI at stake

The controversy surrounding the appointment of Rakesh Asthana and how the probe into his misdemeanours is being thwarted, raises the question of whether the government exercises political discretion in selecting candidates who are pliant to their agenda.

October 24, 2018 / 21:46 IST
Story continues below Advertisement

IMA Ponzi scheme case: A multi-crore scheme run by Karnataka-based I-Monetary Advisory (IMA) and its group entities allegedly duped lakhs of people by promising higher returns using Islamic ways of investment. The Central Bureau of Investigation (CBI) is currently investigating the case and has filed at least three FIRs. (File image of the CBI headquarters)

Moneycontrol News

The Enforcement Directorate (ED) filed its charge sheet under the Prevention of Money Laundering Act against Gujarat-based Sterling Biotech on October 24, naming 195 persons and entities. The move to act against Sterling Biotech comes in the backdrop of the internecine battle for power at the Central Bureau of Investigation (CBI), a constitutional body mandated to act independently despite being staffed by government appointees.

Story continues below Advertisement

The government could find itself hemmed in as the spat between CBI Director Alok Verma and Deputy Director Rakesh Asthana unravels, affecting both the credibility of the organisation, and the government’s reputation as a neutral facilitator in the working of constitutional bodies.

On October 21, the CBI named Asthana as an accused in the Sterling Biotech case, an unprecedented event in the history of the institution. The CBI said that Asthana is being investigated for wrongdoing in six other cases as well.